{{Rsnum
|rsid=795491
|Gene=PRDX4
|Chromosome=X
|position=23680746
|Orientation=plus
|GMAF=0.3803
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=PRDX4
}}{{PharmGKB
|RSID=rs795491
|Name_s=rs795491 T/A PRDX4
|Gene_s=PRDX4
|Feature=
|Evidence=PubMed ID:20157331
|Annotation=Risk or phenotype-associated allele: Not specified. Phenotype: This SNP was associated with clearance of docetaxel. Study size: 31. Study population/ethnicity: Patients with Non-Small-Cell Lung Carcinoma. Significance metric(s): p = 0.0203 (ANOVA); p = 0.0552 (QMIS); p = 0.0003 (KW) Type of association: PK.
|Drugs=docetaxel
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165291801
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs795491
|overall_frequency_n=35
|overall_frequency_d=54
|overall_frequency=0.648148
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=51
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}
{{on chip | 23andMe v3}}